Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility

prnasiaJuly 27, 2021

Tag: Wuxi Biologics , Leverkusen , DP7 , Bayer

PharmaSources Customer Service